Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0016020 | membrane | 2 | 10 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: E9AEZ3
Term | Name | Level | Count |
---|---|---|---|
GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 11 |
GO:0006457 | protein folding | 2 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 2 |
GO:0018193 | peptidyl-amino acid modification | 5 | 11 |
GO:0018208 | peptidyl-proline modification | 6 | 11 |
GO:0019538 | protein metabolic process | 3 | 11 |
GO:0036211 | protein modification process | 4 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0043412 | macromolecule modification | 4 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0005488 | binding | 1 | 2 |
GO:0016018 | cyclosporin A binding | 4 | 2 |
GO:0016853 | isomerase activity | 2 | 11 |
GO:0016859 | cis-trans isomerase activity | 3 | 11 |
GO:0033218 | amide binding | 2 | 2 |
GO:0042277 | peptide binding | 3 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 76 | 80 | PF00656 | 0.671 |
CLV_MEL_PAP_1 | 8 | 14 | PF00089 | 0.508 |
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.520 |
CLV_NRD_NRD_1 | 253 | 255 | PF00675 | 0.482 |
CLV_NRD_NRD_1 | 436 | 438 | PF00675 | 0.751 |
CLV_PCSK_FUR_1 | 135 | 139 | PF00082 | 0.445 |
CLV_PCSK_KEX2_1 | 137 | 139 | PF00082 | 0.449 |
CLV_PCSK_KEX2_1 | 253 | 255 | PF00082 | 0.482 |
CLV_PCSK_KEX2_1 | 366 | 368 | PF00082 | 0.586 |
CLV_PCSK_KEX2_1 | 438 | 440 | PF00082 | 0.736 |
CLV_PCSK_PC1ET2_1 | 366 | 368 | PF00082 | 0.586 |
CLV_PCSK_PC1ET2_1 | 438 | 440 | PF00082 | 0.736 |
CLV_PCSK_SKI1_1 | 152 | 156 | PF00082 | 0.388 |
CLV_PCSK_SKI1_1 | 310 | 314 | PF00082 | 0.482 |
DEG_APCC_DBOX_1 | 137 | 145 | PF00400 | 0.642 |
DEG_APCC_DBOX_1 | 309 | 317 | PF00400 | 0.282 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.774 |
DEG_ODPH_VHL_1 | 385 | 398 | PF01847 | 0.493 |
DOC_CYCLIN_RxL_1 | 134 | 145 | PF00134 | 0.639 |
DOC_MAPK_DCC_7 | 20 | 30 | PF00069 | 0.709 |
DOC_MAPK_gen_1 | 135 | 143 | PF00069 | 0.656 |
DOC_MAPK_MEF2A_6 | 135 | 143 | PF00069 | 0.644 |
DOC_MAPK_MEF2A_6 | 152 | 161 | PF00069 | 0.579 |
DOC_MAPK_MEF2A_6 | 180 | 189 | PF00069 | 0.392 |
DOC_PP1_RVXF_1 | 14 | 20 | PF00149 | 0.686 |
DOC_SPAK_OSR1_1 | 18 | 22 | PF12202 | 0.631 |
DOC_USP7_MATH_1 | 26 | 30 | PF00917 | 0.753 |
DOC_USP7_MATH_1 | 312 | 316 | PF00917 | 0.280 |
DOC_USP7_MATH_2 | 300 | 306 | PF00917 | 0.362 |
DOC_WW_Pin1_4 | 321 | 326 | PF00397 | 0.271 |
DOC_WW_Pin1_4 | 38 | 43 | PF00397 | 0.771 |
LIG_14-3-3_CanoR_1 | 138 | 144 | PF00244 | 0.637 |
LIG_14-3-3_CanoR_1 | 152 | 161 | PF00244 | 0.549 |
LIG_14-3-3_CanoR_1 | 310 | 320 | PF00244 | 0.282 |
LIG_14-3-3_CanoR_1 | 408 | 414 | PF00244 | 0.490 |
LIG_14-3-3_CanoR_1 | 48 | 54 | PF00244 | 0.774 |
LIG_Actin_WH2_2 | 201 | 218 | PF00022 | 0.363 |
LIG_BRCT_BRCA1_1 | 323 | 327 | PF00533 | 0.282 |
LIG_EH1_1 | 18 | 26 | PF00400 | 0.597 |
LIG_FHA_1 | 299 | 305 | PF00498 | 0.338 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.747 |
LIG_FHA_2 | 140 | 146 | PF00498 | 0.665 |
LIG_FHA_2 | 153 | 159 | PF00498 | 0.578 |
LIG_IRF3_LxIS_1 | 325 | 332 | PF10401 | 0.219 |
LIG_LIR_Nem_3 | 219 | 225 | PF02991 | 0.312 |
LIG_SH2_NCK_1 | 348 | 352 | PF00017 | 0.362 |
LIG_SH2_NCK_1 | 393 | 397 | PF00017 | 0.448 |
LIG_SH2_STAP1 | 172 | 176 | PF00017 | 0.355 |
LIG_SH2_STAT3 | 336 | 339 | PF00017 | 0.282 |
LIG_SH2_STAT5 | 192 | 195 | PF00017 | 0.422 |
LIG_SH2_STAT5 | 222 | 225 | PF00017 | 0.308 |
LIG_SH2_STAT5 | 247 | 250 | PF00017 | 0.271 |
LIG_SH2_STAT5 | 298 | 301 | PF00017 | 0.282 |
LIG_SH2_STAT5 | 369 | 372 | PF00017 | 0.362 |
LIG_SH3_3 | 144 | 150 | PF00018 | 0.620 |
LIG_SUMO_SIM_anti_2 | 155 | 161 | PF11976 | 0.570 |
LIG_SUMO_SIM_par_1 | 139 | 146 | PF11976 | 0.650 |
LIG_TYR_ITIM | 220 | 225 | PF00017 | 0.309 |
LIG_ULM_U2AF65_1 | 437 | 442 | PF00076 | 0.547 |
MOD_CK1_1 | 29 | 35 | PF00069 | 0.770 |
MOD_CK1_1 | 58 | 64 | PF00069 | 0.738 |
MOD_CK2_1 | 139 | 145 | PF00069 | 0.665 |
MOD_CK2_1 | 152 | 158 | PF00069 | 0.583 |
MOD_GlcNHglycan | 332 | 335 | PF01048 | 0.475 |
MOD_GlcNHglycan | 409 | 412 | PF01048 | 0.682 |
MOD_GlcNHglycan | 432 | 435 | PF01048 | 0.768 |
MOD_GlcNHglycan | 49 | 52 | PF01048 | 0.541 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.543 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.341 |
MOD_GSK3_1 | 223 | 230 | PF00069 | 0.404 |
MOD_GSK3_1 | 298 | 305 | PF00069 | 0.347 |
MOD_GSK3_1 | 376 | 383 | PF00069 | 0.414 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.761 |
MOD_N-GLC_1 | 227 | 232 | PF02516 | 0.562 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.742 |
MOD_NEK2_1 | 174 | 179 | PF00069 | 0.480 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.347 |
MOD_NEK2_1 | 329 | 334 | PF00069 | 0.329 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.730 |
MOD_NEK2_1 | 380 | 385 | PF00069 | 0.423 |
MOD_NEK2_1 | 392 | 397 | PF00069 | 0.397 |
MOD_NEK2_1 | 47 | 52 | PF00069 | 0.693 |
MOD_PIKK_1 | 424 | 430 | PF00454 | 0.566 |
MOD_PK_1 | 129 | 135 | PF00069 | 0.679 |
MOD_PK_1 | 216 | 222 | PF00069 | 0.329 |
MOD_PKA_1 | 253 | 259 | PF00069 | 0.282 |
MOD_PKA_2 | 253 | 259 | PF00069 | 0.282 |
MOD_PKA_2 | 407 | 413 | PF00069 | 0.506 |
MOD_PKA_2 | 47 | 53 | PF00069 | 0.773 |
MOD_PKA_2 | 68 | 74 | PF00069 | 0.744 |
MOD_Plk_2-3 | 111 | 117 | PF00069 | 0.612 |
MOD_Plk_4 | 139 | 145 | PF00069 | 0.640 |
MOD_Plk_4 | 216 | 222 | PF00069 | 0.330 |
MOD_ProDKin_1 | 321 | 327 | PF00069 | 0.271 |
MOD_ProDKin_1 | 38 | 44 | PF00069 | 0.773 |
MOD_SUMO_for_1 | 125 | 128 | PF00179 | 0.736 |
MOD_SUMO_rev_2 | 332 | 338 | PF00179 | 0.386 |
MOD_SUMO_rev_2 | 397 | 405 | PF00179 | 0.415 |
TRG_DiLeu_BaLyEn_6 | 39 | 44 | PF01217 | 0.771 |
TRG_ENDOCYTIC_2 | 172 | 175 | PF00928 | 0.335 |
TRG_ENDOCYTIC_2 | 222 | 225 | PF00928 | 0.308 |
TRG_ENDOCYTIC_2 | 348 | 351 | PF00928 | 0.362 |
TRG_ENDOCYTIC_2 | 393 | 396 | PF00928 | 0.412 |
TRG_ER_diArg_1 | 135 | 138 | PF00400 | 0.717 |
TRG_ER_diArg_1 | 16 | 19 | PF00400 | 0.702 |
TRG_ER_diArg_1 | 436 | 439 | PF00400 | 0.537 |
TRG_NES_CRM1_1 | 151 | 166 | PF08389 | 0.656 |
TRG_NLS_MonoCore_2 | 436 | 441 | PF00514 | 0.547 |
TRG_NLS_MonoExtN_4 | 437 | 442 | PF00514 | 0.547 |
TRG_Pf-PMV_PEXEL_1 | 152 | 156 | PF00026 | 0.387 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJJ3 | Leptomonas seymouri | 68% | 98% |
A0A1X0P6T5 | Trypanosomatidae | 77% | 100% |
A0A3S7X941 | Leishmania donovani | 94% | 100% |
A0A422NQ98 | Trypanosoma rangeli | 72% | 100% |
A4HMJ2 | Leishmania braziliensis | 83% | 100% |
A4IB72 | Leishmania infantum | 94% | 100% |
C9ZZI1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 74% | 100% |
E9B649 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
V5BP10 | Trypanosoma cruzi | 71% | 100% |